Methyl-1-testosterone

Methyl-1-testosterone (or M1T) is a synthetic anabolic steroid. It is a derivative of dihydrotestosterone (DHT), altered to increase its anabolic activity. M1T is marketed for bodybuilding purposes and is considered a performance-enhancing drug.

History

Methyl-1-testosterone was first described in 1962. It was marketed for medical use, particularly for the treatment of testosterone deficiency in men, under the brand name Metesto. However, it was withdrawn from the market in the 1970s due to concerns about its potential for liver toxicity.

Pharmacology

Methyl-1-testosterone is a synthetic derivative of testosterone, the primary male sex hormone. It has been modified to increase its anabolic (muscle-building) activity relative to its androgenic (masculinizing) activity. This is achieved by the addition of a methyl group at the 1 position on the steroid molecule, which reduces the hormone's androgenic properties and enhances its anabolic properties.

Side Effects

The use of Methyl-1-testosterone can lead to a number of side effects, including liver damage, cardiovascular disease, and changes in mood and behavior. It can also cause masculinization in women and children who are exposed to it.

Legal Status

Methyl-1-testosterone is classified as a Schedule III controlled substance in the United States, meaning it is illegal to possess without a prescription. It is also banned by most major sports organizations.

See Also

• Anabolic steroid
• Dihydrotestosterone
• Testosterone

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia